Reviewing Prestige Consumer Healthcare Inc. (PBH)’s and Apollo Endosurgery Inc. (NASDAQ:APEN)’s resultsDecember 8, 2019
Prestige Consumer Healthcare Inc. (NYSE:PBH) and Apollo Endosurgery Inc. (NASDAQ:APEN) compete against each other in the Medical Appliances & Equipment sector. We will compare them and contrast their analyst recommendations, profitability, risk, institutional ownership, dividends, earnings and valuation.
Valuation and Earnings
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Prestige Consumer Healthcare Inc.||37||2.25||50.08M||-0.71||0.00|
|Apollo Endosurgery Inc.||3||0.00||9.52M||-1.81||0.00|
Demonstrates Prestige Consumer Healthcare Inc. and Apollo Endosurgery Inc. earnings per share, gross revenue and valuation.
Table 2 represents Prestige Consumer Healthcare Inc. (NYSE:PBH) and Apollo Endosurgery Inc. (NASDAQ:APEN)’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Prestige Consumer Healthcare Inc.||135,387,942.69%||-3.1%||-1%|
|Apollo Endosurgery Inc.||329,959,794.81%||-117.1%||-49.9%|
Volatility & Risk
Prestige Consumer Healthcare Inc. is 9.00% less volatile than S&P 500 because the stock has a beta of 0.91. From a competition point of view, Apollo Endosurgery Inc. has a 0.75 beta which is 25.00% less volatile compared to S&P 500.
The current Quick Ratio of Prestige Consumer Healthcare Inc. is 1.4 while its Current Ratio is 2.4. Meanwhile, Apollo Endosurgery Inc. has a Current Ratio of 2.8 while its Quick Ratio is 2.2. Apollo Endosurgery Inc. is better positioned to pay off its short-term and long-term debts than Prestige Consumer Healthcare Inc.
In next table is given Prestige Consumer Healthcare Inc. and Apollo Endosurgery Inc.’s ratings and recommendations.
|Sell Ratings||Hold Ratings||Buy Ratings||Rating Score|
|Prestige Consumer Healthcare Inc.||0||1||0||2.00|
|Apollo Endosurgery Inc.||0||0||0||0.00|
The consensus price target of Prestige Consumer Healthcare Inc. is $32, with potential downside of -16.27%.
Insider and Institutional Ownership
Roughly 44.05% of Prestige Consumer Healthcare Inc. shares are owned by institutional investors while 65.8% of Apollo Endosurgery Inc. are owned by institutional investors. Insiders owned roughly 0.5% of Prestige Consumer Healthcare Inc.’s shares. Competitively, 13.9% are Apollo Endosurgery Inc.’s share owned by insiders.
In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.
|Performance (W)||Performance (M)||Performance (Q)||Performance (HY)||Performance (Y)||Performance (YTD)|
|Prestige Consumer Healthcare Inc.||3.84%||6.4%||19.19%||25.45%||-3.73%||12.05%|
|Apollo Endosurgery Inc.||-2.15%||-12.5%||-25.82%||-23.1%||-66.95%||-20.87%|
For the past year Prestige Consumer Healthcare Inc. has 12.05% stronger performance while Apollo Endosurgery Inc. has -20.87% weaker performance.
Prestige Consumer Healthcare Inc. beats Apollo Endosurgery Inc. on 8 of the 11 factors.
Prestige Brands Holdings, Inc.,…